血清β_2-微球蛋白及尿白蛋白与早期糖尿病肾病相关性研究  

The Serum β_2-Microglobulin and Urinary Protein and Early Diabetic Nephropathy Correlation Study

作　　者：张远珍 徐天祥[1] 

机构地区：[1]江苏省句容市人民医院,212400

出　　处：《首都医药》2013年第8期27-27,共1页Capital Medicine

摘　　要：目的血清β2-微球蛋白、尿微量白蛋白的测定在早期糖尿病肾病诊断中的意义。方法采用散射比浊法,对常规检测尿蛋白阴性的糖尿病患者进行血清β2-微球蛋白、尿白蛋白的含量检测。结果糖尿病尿蛋白阴性患者的血清β2-微球蛋白及尿白蛋白的含量均显著高于正常对照组。结论联检血β2-微球蛋白、尿白蛋白是预测糖尿病肾损害的简便可行的方法,对糖尿病肾病的早期诊断具有重要的临床价值。Objective To explore diagnosis value of serun[~2- microglobulin（[~2-MG） and urinary microalbumi （mhlb） in early diabetic nephropathy （DN）. [32-MG and mAlb immunodiffus ion Method The serum were measured by turbidimetry in diabetes patients with routine urine examination protein negative. Results The serum β2-MG and mAlb routine urine examination protein negative group was significantly higher than that in normal control group Conclusion Combined determination of serum β2-MG and mhlb is feasible method to forecast diabetic kidney damage and helpful for diagnosis and assessment of early diabetic nephropathy.

关 键 词：血清Β2-微球蛋白 尿微量白蛋白 糖尿病肾病 

分 类 号：R446.1[医药卫生—诊断学]